BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33529662)

  • 21. Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation.
    Barbanti M; Capranzano P; Ohno Y; Gulino S; Sgroi C; Immè S; Tamburino C; Cannata S; Patanè M; Di Stefano D; Todaro D; Di Simone E; Deste W; Gargiulo G; Capodanno D; Grasso C; Tamburino C
    EuroIntervention; 2015 Oct; 11(6):690-7. PubMed ID: 26499222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propensity-matched comparison of vascular closure devices after transcatheter aortic valve replacement using MANTA versus ProGlide.
    Moriyama N; Lindström L; Laine M
    EuroIntervention; 2019 Feb; 14(15):e1558-e1565. PubMed ID: 30295293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
    Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
    Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of percutaneous femoral arteriotomy closure using the MANTA
    De Palma R; Settergren M; Rück A; Linder R; Saleh N
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):954-961. PubMed ID: 29575678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular complications of ProGlide versus Prostar in transcatheter aortic valve replacement (TAVR) procedures: meta-analysis.
    Xiang Y; Chen C; Zhao J; Ma Y; Huang B; Wu Z
    BJS Open; 2023 Jul; 7(4):. PubMed ID: 37498966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new Percutaneous technique for effective vascular Access Site closure in patients undergoing Transfemoral aortic valve implantation and thoraco-abdominal aortic aneurysm rEpair: the PASTE study.
    Sorropago G; Singh G; Sorropago A; Sole A; Rossi J; Tolva VS; Stabile E; Scalise F
    EuroIntervention; 2018 Dec; 14(12):e1278-e1285. PubMed ID: 30327287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictability and Outcome of Vascular Complications after Transfemoral Transcatheter Aortic Valve Implantation.
    Uguz E; Gokcimen M; Ali S; Alsancak Y; Bastug S; Ahmet Kasapkara H; Canyigit M; Hıdıroglu M; Sener E
    J Heart Valve Dis; 2016 Mar; 25(2):173-181. PubMed ID: 27989061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ProGlide vs. Prostar in patients undergoing transcatheter aortic valve implantation.
    Giordano A; Corcione N; Ferraro P; Morello A; Conte S; Testa L; Iadanza A; Sardella G; Mancone M; Berti S; Petronio AS; Romagnoli E; Pepe M; Frati G; Biondi-Zoccai G;
    Minerva Cardioangiol; 2019 Dec; 67(6):443-449. PubMed ID: 31670491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Totally Percutaneous Transfemoral Transcatheter Aortic Valve Replacement Despite Failure to Deploy a Vascular Closure Device: A Single-Centre Case Series.
    Eitan A; Shiran A; Sliman H; Zafrir B; Jaffe R
    Heart Lung Circ; 2022 Mar; 31(3):390-394. PubMed ID: 34607752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angio-Seal Used as a Bailout for Incomplete Hemostasis After Dual Perclose ProGlide Deployment in Transcatheter Aortic Valve Implantation.
    Cakal B; Cakal S; Karaca O; Yilmaz FK; Gunes HM; Yildirim A; Ulas Ozcan O; Guler Y; Boztosun B
    Tex Heart Inst J; 2022 Nov; 49(6):. PubMed ID: 36515932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk Factors for Closure Failure following Percutaneous Transfemoral Transcatheter Aortic Valve Implantation.
    Lee CH; Ko YG; Park Y; Shim CY; Hong GR; Lee SH; Lee S; Jung HW; Hong SJ; Ahn CM; Kim JS; Kim BK; Choi D; Hong MK; Jang Y
    Ann Vasc Surg; 2020 Jul; 66():406-414. PubMed ID: 31918036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of MANTA vs suture-based vascular closure devices after transcatheter aortic valve replacement: An updated meta-analysis.
    Doshi R; Vasudev R; Guragai N; Patel KN; Kumar A; Majmundar M; Doshi P; Patel P; Shah K; Santana M; Roman S; Vallabhajosyula S; Virk H; Bikkina M; Shamoon F
    Indian Heart J; 2023; 75(1):59-67. PubMed ID: 36640840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation.
    Costa G; Valvo R; Picci A; Criscione E; Reddavid C; Motta S; Strazzieri O; Deste W; Giuffrida A; Garretto V; Cannizzaro MT; Inserra C; Veroux P; Giaquinta A; Sgroi C; Tamburino C; Barbanti M
    EuroIntervention; 2021 Oct; 17(9):728-735. PubMed ID: 33589411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimalistic Approach for Transcatheter Aortic Valve Implantation (TAVI): Open Vascular Vs. Fully Percutaneous Approach.
    Kedev S; Zafirovska B; Srbinovska-Kostovska E; Antov S; Nikolic A; Dzemali O; Bunc M
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):5-14. PubMed ID: 31605589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous plug-based vascular closure device in 1000 consecutive transfemoral transcatheter aortic valve implantations.
    Kastengren M; Settergren M; Rück A; Feldt K; Saleh N; Linder R; Verouhis D; Meduri CU; Bager J; Dalén M
    Int J Cardiol; 2022 Jul; 359():7-13. PubMed ID: 35427700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of hybrid vascular closure technique using both a suture- and collagen-mediated closure device after transfemoral transcatheter aortic valve implantation.
    Al-Ani A; Hoffmann P; von Lueder T; Opdahl A
    Catheter Cardiovasc Interv; 2020 May; 95(6):1171-1175. PubMed ID: 31379116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Saleh N; De Palma R; Settergren M; Rück A
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
    Barbash IM; Wasserstrum Y; Erlebach M; Guetta V; Ziegelmüller J; Segev A; Fefer P; Maor E; Lange R; Ruge H
    Catheter Cardiovasc Interv; 2024 Jan; 103(1):160-168. PubMed ID: 38059295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early Outcomes After Percutaneous Closure of Access Site in Transfemoral Transcatheter Valve Implantation Using the Novel Vascular Closure Device Collagen Plug-Based MANTA.
    Gheorghe L; Brouwer J; Mathijssen H; Nijenhuis VJ; Rensing BJ; Swaans MJ; Chan Pin Yin DR; Heijmen RH; De Kroon T; Sonker U; Van der Heyden JA; Ten Berg JM
    Am J Cardiol; 2019 Oct; 124(8):1265-1271. PubMed ID: 31443900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Access site related vascular complications with third generation transcatheter heart valve systems.
    Ruge H; Burri M; Erlebach M; Lange R
    Catheter Cardiovasc Interv; 2021 Feb; 97(2):325-332. PubMed ID: 32588968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.